BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

USPLABS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

USPLABS

via PARRY, ROMANI, DECONCINI & SYMMS

4th Quarter (Oct 1 - Dec 31) · 2013Posted Dec 30, 2013Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: USPLABS
Description: Dietary supplement manufacturer.
Location: Texas · United States of America

Registrant

Firm: PARRY, ROMANI, DECONCINI & SYMMS
Description: Consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
FDA oversight of supplement industry. No applicable legislation.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM · JAMES ROCK · mr EDWARD H BAXTER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.